Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Open accessThe DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Abstract
Bacteriophages (phages) are viruses that infect bacteria. The "predator-prey" interactions are recognized as a potentially effective way to treat infections. Phages, as well as phage-derived proteins, especially enzymes, are intensively studied to become future alternative or supportive antibacterials used alone or in combination with standard antibiotic regimens treatment. There are many publications presenting phage therapy aspects, and some papers focused separately on the application of phage-derived enzymes. In this review, we discuss advantages and limitations of both agents concerning their specificity, mode of action, structural issues, resistance development, pharmacokinetics, product preparation, and interactions with the immune system. Finally, we describe the current regulations for phage-based product application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, bacteriophages as therapeutic strategies could modulate the gut microbiota, immunity, and TME [70, 164–166].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [166]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Climate Change 2013 – The Physical Science Basis · doi:10.1017/cbo9781107415324.004 · Cited by 23,880
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
Peptidoglycan types of bacterial cell walls and their taxonomic implications
Schleifer, K. H., & Kandler, O. (1972) · Bacteriological Reviews · doi:10.1128/mmbr.36.4.407-477.1972 · Cited by 4,223
Peptidoglycan types of bacterial cell walls and their taxonomic implications
Schleifer, K. H., & Kandler, O. (1972) · Bacteriological Reviews · doi:10.1128/br.36.4.407-477.1972 · Cited by 4,222
Valen, L. M. V. (1973) · Medical Entomology and Zoology · Cited by 2,448
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Virioplankton: Viruses in Aquatic Ecosystems
Wommack, K. E., & Colwell, R. R. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.69-114.2000 · Cited by 2,160
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Bacterial peptidoglycan (murein) hydrolases
Vollmer, W., Joris, B., Charlier, P., & Foster, S. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00099.x · Cited by 886
A century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases
Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731
The influence of external factors on bacteriophages—review
Jończyk, E., Kłak, M., Międzybrodzki, R., & Górski, A. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0039-8 · Cited by 705
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Communication between viruses guides lysis–lysogeny decisions
Erez, Z., Steinberger-Levy, I., Shamir, M., Doron, S., Stokar-Avihail, A., Peleg, Y., Melamed, S., Leavitt, A., Savidor, A., Albeck, S., et al. (2017) · Nature · doi:10.1038/nature21049 · Cited by 648
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications
Pires, D. P., Oliveira, H., Melo, L. D. R., Sillankorva, S., & Azeredo, J. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7247-0 · Cited by 517
BREX is a novel phage resistance system widespread in microbial genomes
Goldfarb, T., Sberro, H., Weinstock, E., Cohen, O., Doron, S., Charpak‐Amikam, Y., Afik, S., Ofir, G., & Sorek, R. (2015) · The EMBO Journal · doi:10.15252/embj.201489455 · Cited by 514
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Phage therapy: past history and future prospects.
Carlton, R. M. (1999) · PubMed · Cited by 442
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Fischetti, V. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.002 · Cited by 438
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Gram-positive and gram-negative bacterial toxins in sepsis: A brief review
Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411
Bacteriophage lytic enzymes: novel anti-infectives
Fischetti, V. A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.08.007 · Cited by 400
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Latka, A., Maciejewska, B., Majkowska-Skrobek, G., Briers, Y., & Drulis-Kawa, Z. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8224-6 · Cited by 376
Self-citationClinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
Phage on tap–a quick and efficient protocol for the preparation of bacteriophage laboratory stocks
Bonilla, N., Rojas, M. I., Netto Flores Cruz, G., Hung, S.-H., Rohwer, F., & Barr, J. J. (2016) · PeerJ · doi:10.7717/peerj.2261 · Cited by 353
Novel type of murein transglycosylase in Escherichia coli
Höltje, J. V., Mirelman, D., Sharon, N., & Schwarz, U. (1975) · Journal of Bacteriology · doi:10.1128/jb.124.3.1067-1076.1975 · Cited by 340
Polymeric Nanoparticles for Drug Delivery
Chan, J. M., Valencia, P. M., Zhang, L., Langer, R., & Farokhzad, O. C. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_11 · Cited by 339
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
Bacteriophages show promise as antimicrobial agents
Alisky, J., Iczkowski, K., Rapoport, A., & Troitsky, N. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92874-2 · Cited by 318
Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017) · Current Microbiology · doi:10.1007/s00284-016-1166-x · Cited by 318
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
Barrow, P. A., & Soothill, J. S. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01054-8 · Cited by 280
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
Global-scale processes with a nanoscale drive: the role of marine viruses
Brussaard, C. P., Wilhelm, S. W., Thingstad, F., Weinbauer, M. G., Bratbak, G., Heldal, M., Kimmance, S. A., Middelboe, M., Nagasaki, K., Paul, J. H., et al. (2008) · The ISME Journal · doi:10.1038/ismej.2008.31 · Cited by 268
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Bacteriophage penetration in vertebrates
Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B., & Gorski, A. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02422.x · Cited by 240
Nau, R., & Eiffert, H. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.95-110.2002 · Cited by 240
Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. J., & Fischetti, V. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01625-09 · Cited by 233
Yoong, P., Schuch, R., Nelson, D., & Fischetti, V. A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4808-4812.2004 · Cited by 233
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
Ryan, E. M., Gorman, S. P., Donnelly, R. F., & Gilmore, B. F. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01324.x · Cited by 227
Górski, A., Ważna, E., DÄ browska, B.-W., DÄ browska, K., ÅwitaÅa-JeleÅ, K., & MiÄdzybrodzki, R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00044.x · Cited by 227
Sass, P., & Bierbaum, G. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01616-06 · Cited by 222
Effective Removal of Staphylococcal Biofilms by the Endolysin LysH5
Gutiérrez, D., Ruas-Madiedo, P., Martínez, B., Rodríguez, A., & García, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107307 · Cited by 217
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Jado, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg485 · Cited by 216
Gilmer, D. B., Schmitz, J. E., Euler, C. W., & Fischetti, V. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02526-12 · Cited by 216
Overview of the Purification of Recombinant Proteins
Wingfield, P. T. (2015) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0601s80 · Cited by 214
Chan, B. K., & Abedon, S. T. (2012) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-394805-2.00001-4 · Cited by 212
Oliveira, H., Thiagarajan, V., Walmagh, M., Sillankorva, S., Lavigne, R., Neves-Petersen, M. T., Kluskens, L. D., & Azeredo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108376 · Cited by 207
Phage therapy dosing: The problem(s) with multiplicity of infection (MOI)
Abedon, S. T. (2016) · Bacteriophage · doi:10.1080/21597081.2016.1220348 · Cited by 201
Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C. W., Hertveldt, K., & Lavigne, R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05870.x · Cited by 197
A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
Guo, M., Feng, C., Ren, J., Zhuang, X., Zhang, Y., Zhu, Y., Dong, K., He, P., Guo, X., & Qin, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00293 · Cited by 190
Pastagia, M., Euler, C., Chahales, P., Fuentes-Duculan, J., Krueger, J. G., & Fischetti, V. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00890-10 · Cited by 188
Cornelissen, A., Ceyssens, P.-J., T'Syen, J., Van Praet, H., Noben, J.-P., Shaburova, O. V., Krylov, V. N., Volckaert, G., & Lavigne, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018597 · Cited by 185
Jun, S. Y., Jang, I. J., Yoon, S., Jang, K., Yu, K.-S., Cho, J. Y., Seong, M.-W., Jung, G. M., Yoon, S. J., & Kang, S. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02629-16 · Cited by 184
Bacteriophage Procurement for Therapeutic Purposes
Weber-Dąbrowska, B., Jończyk-Matysiak, E., Żaczek, M., Łobocka, M., Łusiak-Szelachowska, M., & Górski, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01177 · Cited by 178
Gu, J., Xu, W., Lei, L., Huang, J., Feng, X., Sun, C., Du, C., Zuo, J., Li, Y., Du, T., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01144-10 · Cited by 174
Schmelcher, M., Powell, A. M., Becker, S. C., Camp, M. J., & Donovan, D. M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07050-11 · Cited by 172
Łoś, M., & Węgrzyn, G. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394621-8.00019-4 · Cited by 165
Totté, J. E. E., van Doorn, M. B., & Pasmans, S. G. M. A. (2017) · Case Reports in Dermatology · doi:10.1159/000473872 · Cited by 161
Schmelcher, M., Shen, Y., Nelson, D. C., Eugster, M. R., Eichenseher, F., Hanke, D. C., Loessner, M. J., Dong, S., Pritchard, D. G., Lee, J. C., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku552 · Cited by 160
Safety and efficacy of phage therapy via the intravenous route
Speck, P., & Smithyman, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv242 · Cited by 160
Briers, Y., Walmagh, M., & Lavigne, R. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04931.x · Cited by 159
Mayer, M. J., Narbad, A., & Gasson, M. J. (2008) · Journal of Bacteriology · doi:10.1128/jb.00686-08 · Cited by 158
Oliveira, H., Vilas Boas, D., Mesnage, S., Kluskens, L. D., Lavigne, R., Sillankorva, S., Secundo, F., & Azeredo, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00208 · Cited by 157
Clinical relevance of antibiotic-induced endotoxin release
Prins, J. M., van Deventer, S. J. H., Kuijper, E. J., & Speelman, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1211 · Cited by 151
Entenza, J. M., Loeffler, J. M., Grandgirard, D., Fischetti, V. A., & Moreillon, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4789-4792.2005 · Cited by 150
Goodridge, L. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725348 · Cited by 147
Nongenetic Individuality in the Host–Phage Interaction
Pearl, S., Gabay, C., Kishony, R., Oppenheim, A., & Balaban, N. Q. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060120 · Cited by 141
Majkowska-Skrobek, G., Łątka, A., Berisio, R., Maciejewska, B., Squeglia, F., Romano, M., Lavigne, R., Struve, C., & Drulis-Kawa, Z. (2016) · Viruses · doi:10.3390/v8120324 · Cited by 140
Self-citationRapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin
Shen, Y., Köller, T., Kreikemeyer, B., & Nelson, D. C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt104 · Cited by 138
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia*
Witzenrath, M., Schmeck, B., Doehn, J. M., Tschernig, T., Zahlten, J., Loeffler, J. M., Zemlin, M., Müller, H. C., Gutbier, B., Schütte, H., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819586a6 · Cited by 136
Díez‐Martínez, R., de Paz, H. D., García‐Fernández, E., Bustamante, N., Euler, C. W., Fischetti, V. A., Menéndez, M., & García, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv038 · Cited by 133
Son, J. S., Lee, S.-J., Jun, S. Y., Yoon, S. J., Kang, S. H., Paik, H. R., Kang, J. O., & Choi, Y. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2386-9 · Cited by 133
Pan, Y., Lin, T., Lin, Y.-T., Su, P.-A., Chen, C.-T., Hsieh, P., Hsu, C.-R., Chen, C.-C., Hsieh, Y., & Wang, J.-T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03560-14 · Cited by 132
Bacteriophage-Derived Peptidase CHAPK Eliminates and Prevents Staphylococcal Biofilms
Fenton, M., Keary, R., McAuliffe, O. E., Ross, R. P., O’Mahony, J., & Coffey, A. (2013) · International Journal of Microbiology · doi:10.1155/2013/625341 · Cited by 129
Phage therapy: Should bacterial resistance to phages be a concern, even in the long run?
Örmälä‐Odegrip, A., & Jalasvuori, M. (2013) · Bacteriophage · doi:10.4161/bact.24219 · Cited by 128
Waseh, S., Hanifi-Moghaddam, P., Coleman, R., Masotti, M., Ryan, S., Foss, M., MacKenzie, R., Henry, M., Szymanski, C. M., & Tanha, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013904 · Cited by 128
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
Bull, J. J., Levin, B. R., DeRouin, T., Walker, N., & Bloch, C. A. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-35 · Cited by 127
Cheng, Q., & Fischetti, V. A. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0771-1 · Cited by 120
Temperate bacteriophages as regulators of host behavior
Argov, T., Azulay, G., Pasechnek, A., Stadnyuk, O., Sapir, S. R., Borovok, I., Sigal, N., & Herskovits, A. A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.002 · Cited by 114
The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence
Olszak, T., Shneider, M. M., Latka, A., Maciejewska, B., Browning, C., Sycheva, L. V., Cornelissen, A., Danis-Wlodarczyk, K., Senchenkova, S. N., Shashkov, A. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16411-4 · Cited by 114
Self-citationMeng, X., Shi, Y., Ji, W., Meng, X., Zhang, J., Wang, H., Lu, C., Sun, J., & Yan, Y. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05151-11 · Cited by 113
Guariglia-Oropeza, V., & Helmann, J. D. (2011) · Journal of Bacteriology · doi:10.1128/jb.06023-11 · Cited by 112
Novel Strategy to Prevent Otitis Media Caused by Colonizing Streptococcus pneumoniae
McCullers, J. A., Karlström, Å., Iverson, A. R., Loeffler, J. M., & Fischetti, V. A. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030028 · Cited by 110
Gutiérrez, D., Briers, Y., Rodríguez-Rubio, L., Martínez, B., Rodríguez, A., Lavigne, R., & García, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01315 · Cited by 110
Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria
Abedon, S. T. (2015) · Pharmaceuticals · doi:10.3390/ph8030559 · Cited by 108
Phage Lytic Enzyme Cpl‐1 for Antibacterial Therapy in Experimental Pneumococcal Meningitis
Grandgirard, D., Loeffler, J. M., Fischetti, V. A., & Leib, S. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587942 · Cited by 106
Navarro, F., & Muniesa, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00566 · Cited by 106
Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1
Jun, S. Y., Jung, G. M., Yoon, S. J., Oh, M., Choi, Y., Lee, W. J., Kong, J.-C., Seol, J. G., & Kang, S. H. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.011 · Cited by 105
Mushtaq, N., Redpath, M. B., Luzio, J. P., & Taylor, P. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki177 · Cited by 105
Mushtaq, N., Redpath, M. B., Luzio, J. P., & Taylor, P. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1503-1508.2004 · Cited by 105
Peng, S.-Y., You, R.-I., Lai, M.-J., Lin, N.-T., Chen, L.-K., & Chang, K.-C. (2017) · Scientific Reports · doi:10.1038/s41598-017-11832-7 · Cited by 105
Exogenous Lytic Activity of SPN9CC Endolysin Against Gram-Negative Bacteria
Lim, J.-A., Shin, H., Heu, S., & Ryu, S. (2014) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1403.03035 · Cited by 104
Singh, P. K., Donovan, D. M., & Kumar, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-14 · Cited by 103
Function of bacteriophage G7C esterase tailspike in host cell adsorption
Prokhorov, N. S., Riccio, C., Zdorovenko, E. L., Shneider, M. M., Browning, C., Knirel, Y. A., Leiman, P. G., & Letarov, A. V. (2017) · Molecular Microbiology · doi:10.1111/mmi.13710 · Cited by 103
Jun, S. Y., Jung, G. M., Yoon, S. J., Choi, Y., Koh, W. S., Moon, K., & Kang, S. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02232-13 · Cited by 102
Gupta, R., & Prasad, Y. (2010) · Current Microbiology · doi:10.1007/s00284-010-9699-x · Cited by 101
Thierauf, A., Perez, G., & Maloy, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-164-6_23 · Cited by 100
Yoong, P., Schuch, R., Nelson, D. C., & Fischetti, V. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2711-2714.2006 · Cited by 98
Expression and delivery of an endolysin to combat Clostridium perfringens
Gervasi, T., Horn, N., Wegmann, U., Dugo, G., Narbad, A., & Mayer, M. J. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5128-y · Cited by 96
Domenech, M., García, E., & Moscoso, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00492-11 · Cited by 96
Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?
Abedon, S. T. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv246 · Cited by 96
Gutiérrez, D., Martínez, B., Rodríguez, A., & García, P. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-228 · Cited by 94
Paul, V. D., Rajagopalan, S. S., Sundarrajan, S., George, S. E., Asrani, J. Y., Pillai, R., Chikkamadaiah, R., Durgaiah, M., Sriram, B., & Padmanabhan, S. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-226 · Cited by 91
Information Phage Therapy Research Should Report
Abedon, S. T. (2017) · Pharmaceuticals · doi:10.3390/ph10020043 · Cited by 87
A bacteriophage journey at the European Medicines Agency
Debarbieux, L., Pirnay, J., Verbeken, G., Vos, D. D., Merabishvili, M., Huys, I., Patey, O., Schoonjans, D., Vaneechoutte, M., Zizi, M., et al. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv225 · Cited by 86
Yang, H., Wang, M., Yu, J., & Wei, H. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01471 · Cited by 85
DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N -Acetylmuramidase Activity
Rodríguez‐Rubio, L., Gerstmans, H., Thorpe, S., Mesnage, S., Lavigne, R., & Briers, Y. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00446-16 · Cited by 76
A bacteriophage endolysin that eliminates intracellular streptococci
Shen, Y., Barros, M., Vennemann, T., Gallagher, D. T., Yin, Y., Linden, S. B., Heselpoth, R. D., Spencer, D. J., Donovan, D. M., Moult, J., et al. (2016) · eLife · doi:10.7554/elife.13152 · Cited by 75
Krylov, V. N., Shaburova, O. V., Крылов, С. В., & Pleteneva, E. A. (2012) · Viruses · doi:10.3390/v5010015 · Cited by 73
Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia
Doehn, J.-M., Fischer, K., Reppe, K., Gutbier, B., Tschernig, T., Hocke, A., Fischetti, V. A., Loffler, J., Suttorp, N., Hippenstiel, S., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt131 · Cited by 73
Rodríguez‐Rubio, L., Martínez, B., Donovan, D. M., García, P., & Rodríguez, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054828 · Cited by 71
Zhang, L., Li, D., Li, X., Hu, L., Cheng, M., Xia, F., Gong, P., Wang, B., Ge, J., Zhang, H., et al. (2016) · Scientific Reports · doi:10.1038/srep29344 · Cited by 70
van Langevelde, P., Kwappenberg, K. M. C., Groeneveld, P. H. P., Mattie, H., & van Dissel, J. T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.739 · Cited by 69
Latino, L., Midoux, C., Hauck, Y., Vergnaud, G., & Pourcel, C. (2016) · Microbiology · doi:10.1099/mic.0.000263 · Cited by 68
Maciejewska, B., Roszniowski, B., Espaillat, A., Kęsik-Szeloch, A., Majkowska-Skrobek, G., Kropinski, A. M., Briers, Y., Cava, F., Lavigne, R., & Drulis‐Kawa, Z. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7928-3 · Cited by 67
Self-citationResch, G., Moreillon, P., & Fischetti, V. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.08.009 · Cited by 66
Oechslin, F., Daraspe, J., Giddey, M., Moreillon, P., & Resch, G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01701-13 · Cited by 62
The perspectives of the application of phage therapy in chronic bacterial prostatitis
Letkiewicz, S., Międzybrodzki, R., Kłak, M., Jończyk, E., Weber-Dąbrowska, B., & Górski, A. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00723.x · Cited by 61
Lood, R., Raz, A., Molina, H., Euler, C. W., & Fischetti, V. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-14 · Cited by 60
Płotka, M., Kaczorowska, A., Stefańska, A., Morzywołek, A., Friðjónsson, Ó. H., Dunin-Horkawicz, S., Kozlowski, L. P., Hreggviðsson, G. Ó., Kristjánsson, J. K., Dąbrowski, S., et al. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03074-13 · Cited by 58
Schirmeier, E., Zimmermann, P., Hofmann, V., Biebl, M., Gerstmans, H., Maervoet, V. E. T., & Briers, Y. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.027 · Cited by 56
Jun, S. Y., Jung, G. M., Yoon, S. J., Youm, S. Y., Han, H., Lee, J., & Kang, S. H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12613 · Cited by 49
Rico-Lastres, P., Díez‐Martínez, R., Iglesias-Bexiga, M., Bustamante, N., Aldridge, C., Hesek, D., Lee, M., Mobashery, S., Gray, J., Vollmer, W., et al. (2015) · Scientific Reports · doi:10.1038/srep16198 · Cited by 48
Gupta, R., & Prasad, Y. (2011) · Current Microbiology · doi:10.1007/s00284-011-9939-8 · Cited by 45
McCallum, K. L., Laakso, D. H., & Whitfield, C. (1989) · Canadian Journal of Microbiology · doi:10.1139/m89-166 · Cited by 45
Heselpoth, R. D., Yin, Y., Moult, J., & Nelson, D. C. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv004 · Cited by 44
The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa
Gilmer, D. B., Schmitz, J. E., Thandar, M., Euler, C. W., & Fischetti, V. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169180 · Cited by 44
Kim, M., & Ryu, S. (2013) · Journal of Virology · doi:10.1128/jvi.02173-13 · Cited by 39
Gu, J., Zuo, J., Lei, L., Zhao, H., Sun, C., Feng, X., Du, C., Li, X., Yang, Y., & Han, W. (2011) · Bioengineered Bugs · doi:10.4161/bbug.2.2.14883 · Cited by 34
The Inactivation of Free Bacteriophage by Irradiation and by Chemical Agents
Alper, T. (1954) · Journal of General Microbiology · doi:10.1099/00221287-11-2-313 · Cited by 33
A novel thermophilic lysozyme from bacteriophage φIN93
Matsushita, I., & Yanase, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.101 · Cited by 32
THE BACTERIOPHAGE IN THE TREATMENT OF TYPHOID FEVER
Smith, J. S. (1924) · BMJ · doi:10.1136/bmj.2.3315.47 · Cited by 28
An Addresson BACTERIOPHAGY AND RECOVERY FROM INFECTIOUS DISEASES.
D'herelle, F. (1931) · PubMed · Cited by 26
Verbeken, G., Huys, I., Vos, D. D., Coninck, A. D., Roseeuw, D. I., Kets, E., Vanderkelen, A., Draye, J. P., Rose, T., Jennes, S., et al. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv241 · Cited by 14
Bansal, S., Soni, S. K., Harjai, K., & Chhibber, S. (2013) · Journal of Basic Microbiology · doi:10.1002/jobm.201300356 · Cited by 12
Cited by
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 1,180
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
(2022) · doi:10.1186/s13045-022-01273-9 · Cited by 495
Biotechnological applications of bacteriophages: State of the art
Harada, L. K., Silva, E. C., Campos, W. F., Del Fiol, F. S., Vila, M., Dąbrowska, K., Krylov, V. N., & Balcão, V. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.04.007 · Cited by 318
Abdelrahman, F., Easwaran, M., Daramola, O. I., Ragab, S., Lynch, S., Oduselu, T. J., Khan, F. M., Ayobami, A., Adnan, F., Torrents, E., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10020124 · Cited by 244
Metadata
- Authors
- Maciejewska, B., Olszak, T., & Drulis-Kawa, Z.
- Affiliations
- University of Wrocław (PL)
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2018-02-13
- Volume
- 102
- Issue
- 6
- Pages
- 2563-2581
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- PMC
- PMC5847195
- OpenAlex
- W2789070437
- Cited by
- 222
- References
- 154
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 27 · 2023: 32 · 2022: 31 · 2021: 36 · 2020: 26 · 2019: 25 · 2018: 8
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Applied Microbiology and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Narodowe Centrum Nauki (UMO-2016/21/B/NZ6/01157)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- bacteriophages, phage therapy, bacterial infection, phage resistance, pharmacokinetics, immune interactions, phage specificity
- MeSH terms
- Phage Therapy, Bacterial Infections, Bacteriophages, Enzymes, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.